Tag:
Apeiron Biologics
Latest Headlines
Latest Headlines
Glaxo inks $330M pact for Apeiron lung drug
GlaxoSmithKline is willing to wager up to $330 million on an early-stage lung disease drug in Apeiron Biologics' pipeline. The Austrian biotech struck the deal on APN01, an enzyme biotherapeutic
